Search - tctmd.com

Displaying 401 - 420 of 537

Sort: Relevancy | Date

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

News Daily News

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Michael O'Riordan

February 17, 2017

News Daily News

Meta-analysis Adds Support to More Intensive Lowering of BP in Older Patients With Hypertension

Todd Neale

January 30, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

L.A. McKeown

January 09, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Daily News

Not Following NOAC Dosing Instructions Tied to Worse Clinical Outcomes

Todd Neale

December 12, 2016

News Daily News

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Shelley Wood

December 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Conference News AHA 2016

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Michael O'Riordan

November 13, 2016

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Adam Witkowski

October 30, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Farrell O. Mendelsohn

October 30, 2016

$Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies$

Presentation TCT 2016

Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies

Presenter: Ajay J. Kirtane, Bryan Williams, William B. White

October 30, 2016

Presentation TCT 2016

Pacing-based Treatments of Hypertension: BackBeat Medical

Presenter: Ajay J. Kirtane, Bryan Williams, Karl-Heinz Kuck

October 30, 2016

Presentation TCT 2016

Shunt-based Technologies for Hypertension Control: The Rox Medical Program

Presenter: Ajay J. Kirtane, Bryan Williams, Paul A. Sobotka

October 30, 2016

Presentation TCT 2016

Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies

Presenter: Ajay J. Kirtane, Bryan Williams, Wilko Spiering

October 30, 2016

Presentation TCT 2016

Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results

Presenter: Ajay J. Kirtane, Bryan Williams, Atul Pathak

October 30, 2016

Presentation TCT 2016

Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates?

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness?

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Justin E. Davies

October 30, 2016

Advertisement

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Meta-analysis Adds Support to More Intensive Lowering of BP in Older Patients With Hypertension

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Not Following NOAC Dosing Instructions Tied to Worse Clinical Outcomes

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

TCTMD’s Top 10 Most Popular Stories for November 2016

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies

Pacing-based Treatments of Hypertension: BackBeat Medical

Shunt-based Technologies for Hypertension Control: The Rox Medical Program

Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies

Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results

Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates?

Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content